Fingerprint
Dive into the research topics of 'Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically